Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Efficacy and safety of antiretroviral regimens including raltegravir to treat HIV-infected patients with hemophilia.

Bioscience trends - 1 Feb 2016

Xiao Hong, Xue Yile, Gu Shiming, Wang Jiangrong, Sun Hongqing, Lu Hongzhou

Abstract excerpt

When treating HIV-infected patients with hemophilia, adverse drug reactions and interactions and the effect of treatment on bleeding disorders must be considered. Raltegravir is the first HIV integrase inhibitor, but its use in patients with hemophilia is rarely reported. Nine HIV-positive patients with hemophilia were retrospectively studied with a focus on the virological response, changes in the CD4 count, the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Antiretroviral Therapy, Highly Active

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Viral

Share to Hemophilia A

Share to HIV Infections

Share to Integrases

Share to Raltegravir Potassium

Share to Treatment Outcome

Source

Identifiers

PMID: 26911541
DOI: 10.5582/bst.2015.01180

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Efficacy and safety of antiretroviral regimens including raltegravir to treat HIV-infected patients with hemophilia.PMID 26911541Read ↗

Clinical update: adverse effects of antiretroviral therapySemantic proximity Read ↗

Integrase Strand Transfer Inhibitors in HIV TherapySemantic proximity Read ↗

Approaches for understanding and predicting drug interactions in human immunodeficiency virus-infected patientsSemantic proximity Read ↗

Therapeutic management of HIV.Semantic proximity Read ↗

Raltegravir 1200 mg Once Daily as Maintenance Therapy in Virologically Suppressed HIV-1 Infected Adults : QDISS Open-Label TrialSemantic proximity Read ↗

Efficacy and safety of pegylated interferon alpha-2a therapy for chronic hepatitis C in HIV-infected patients with haemophilia.Semantic proximity Read ↗

A new era of antiretroviral drug toxicity.Semantic proximity Read ↗

HIV related immune thrombocytopenia.Semantic proximity Read ↗

Antiretroviral drugsSemantic proximity Read ↗

The role of raltegravir in the treatment of HIV-2 infections: evidence from a case series.Semantic proximity Read ↗

Antiretroviral therapy 2006: pharmacology, applications, and special situations.Semantic proximity Read ↗

Emerging Pharmacology: Inhibitors of Human Immunodeficiency Virus IntegrationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.